Epstein Secrets

Vaccine Trial To Include Teens. USA Today (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, aiming to include at least 3,000 older teens." Pfizer is the "only one of the leading drug compani

ndly impacted by the economic consequences of this COVID-19 shutdown." Iowa's Economy Suffering Despite No Lockdown. The New York Times (10/22, Al, Casselman, Tankersley, 18.61M) reports President Trump and "many supporters blame restrictions on business activity, often imposed by Democratic governors an

accines' Efficacy For Teens Could Boost Inoculations. USA Today (5/6, Bacon, 12.7M) reports that "encouraging data" recently released by Moderna and Pfizer "on the effectiveness and safety of COVID-19 vaccines for kids" may "ignite much-needed momentum in the lagging national vaccination effort, expert

bers, Rockeman, 3.57M) says that "the median estimate in a Bloomberg survey of economists called for 538,000 claims." But, the New York Times (5/6, Casselman, 20.6M) says applications "remain high by historical standards," and ReiiteN (5/6, Mutikani) that "the labor market is not out of the woods yet, wi

al-trials-pfizer- cincinnati/3709031001/> (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, aiming to include at least 3,000 older teens." Pfizer is the "only one of the leading drug companie

ng Despite No Lockdown. The New York Times <https://www.nytimes.com/2020/10/22/business/economy/economy-coronavirus- lockdown-iowa.html> (10/22, Al, Casselman, Tankersley, 18.61M) reports President Trump and "many supporters blame restrictions on business activity, often imposed by Democratic governors and

dena "expects to have an announcement on the vaccine's efficacy by the end of the month, the company said in a statement Wednesday." Both Modena and Pfizer "use messenger RNA for their vaccines," and NIAID Director Fauci "has said Pfizer's promising outcomes are good news for Moderna, too." Politico <h

ency Federal Jobless Aid Looms. The New York Times <https://vvww.nytimes.com/2020/11/11/business/economy/unemployment-benefits- cutoff.html> (11/11, Casselman, 18.61M) reports "two critical unemployment programs are set to expire at the end of the year, potentially leaving millions of Americans vulnerable

Vaccine Trial To Include Teens. USA Today (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, aiming to include at least 3,000 older teens." Pfizer is the "only one of the leading drug compani

dly impacted by the economic consequences of this COVID-19 shutdown." Iowa's Economy Suffering Despite No Lockdown. The New York Times (10/22, Al, Casselman, Tankersley, 18.61M) reports President Trump and "many supporters blame restrictions on business activity, often imposed by Democratic governors an

na "expects to have an announcement on the vaccine's efficacy by the end of the month, the company said in a statement Wednesday." Both Moderna and Pfizer "use messenger RNA for their vaccines," and NIAID Director Fauci "has said Pfizer's promising outcomes are good news for Moderna, too." Politico (1

rtainly be a top priority for the new administration in early 2021." Expiration Of Emergency Federal Jobless Aid Looms. The New York Times (11/11, Casselman, 18.61M) reports "two critical unemployment programs are set to expire at the end of the year, potentially leaving millions of Americans vulnerable

accines' Efficacy For Teens Could Boost Inoculations. USA Today (5/6, Bacon, 12.7M) reports that "encouraging data" recently released by Moderna and Pfizer "on the effectiveness and safety of COVID-19 vaccines for kids" may "ignite much-needed momentum in the lagging national vaccination effort, expert

bers, Rockeman, 3.57M) says that "the median estimate in a Bloomberg survey of economists called for 538,000 claims." But, the New York Times (5/6, Casselman, 20.6M) says applications "remain high by historical standards," and Reuters (5/6, Mutikani) that "the labor market is not out of the woods yet, wi

na "expects to have an announcement on the vaccine's efficacy by the end of the month, the company said in a statement Wednesday." Both Moderna and Pfizer "use messenger RNA for their vaccines," and NIAID Director Fauci "has said Pfizer's promising outcomes are good news for Moderna, too." Politico (1

rtainly be a top priority for the new administration in early 2021." Expiration Of Emergency Federal Jobless Aid Looms. The New York Times (11/11, Casselman, 18.61M) reports "two critical unemployment programs are set to expire at the end of the year, potentially leaving millions of Americans vulnerable